SCHEMBL4756089

SCHEMBL4756089

CS(=O)(=O)Cc1cnc(NC(=O)c2cccc(OS(C)(=O)=O)c2)s1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SCD O00767 4/20 0.52
ALDH1A1 P00352 5/20 0.47
TSHR P16473 1/20 0.47
NPC1 O15118 9/20 0.45
RAB9A P51151 9/20 0.45
SMN1; SMN2 Q16637 6/20 0.45
HPGD P15428 3/20 0.45
TP53 P04637 2/20 0.44
L3MBTL1 Q9Y468 2/20 0.44
KDM4E B2RXH2 2/20 0.44
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44
GLA P06280 1/20 0.44
POLB P06746 1/20 0.44
HSD17B10 Q99714 1/20 0.44
OPRK1 P41145 1/20 0.43
GAA P10253 2/20 0.43
NPSR1 Q6W5P4 2/20 0.43
LMNA P02545 1/20 0.43
PPARG P37231 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4936103 0.84 NPC1 (0.45) SCDALDH1A1NPC1RAB9ASMN1; SMN2
SCHEMBL4755961 0.84 NPC1 (0.48) SCDALDH1A1NPC1RAB9ASMN1; SMN2
SCHEMBL4756065 0.82 SMN1; SMN2 (0.50) SCDALDH1A1TSHRNPC1RAB9A
SCHEMBL4756028 0.82 NPC1 (0.47) SCDALDH1A1NPC1RAB9ASMN1; SMN2
SCHEMBL4756132 0.82 CCNE1 (0.63) SCDALDH1A1NPC1RAB9ASMN1; SMN2
SCHEMBL4930111 0.80 CCNE1 (0.52) SCDALDH1A1NPC1RAB9ASMN1; SMN2
SCHEMBL4756095 0.79 NPC1 (0.45) SCDALDH1A1NPC1RAB9ASMN1; SMN2
SCHEMBL4756006 0.78 SCD (0.51) SCDALDH1A1TSHRNPC1RAB9A
SCHEMBL4756076 0.77 NPC1 (0.41) SCDALDH1A1NPC1RAB9ASMN1; SMN2
SCHEMBL4755922 0.77 RAB9A (0.71) SCDALDH1A1TSHRNPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8895752-B2 Alkylsulfonyl-substituted thiazolide compounds ROMARK LABORATORIES L.C. (US) 2014-11-25 US disclosed
US-8895752-B2 Alkylsulfonyl-substituted thiazolide compounds ROMARK LABORATORIES L.C. (US) 2014-11-25 US disclosed
US-20120122939-A1 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS ROMARK LABORATORIES, L.C. 2012-05-17 US disclosed
US-20120122939-A1 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS ROMARK LABORATORIES, L.C. 2012-05-17 US disclosed
US-8124632-B2 Alkylsulfonyl-substituted thiazolide compounds ROMARK LABORATORIES, L.C. (US) 2012-02-28 US disclosed
US-8124632-B2 Alkylsulfonyl-substituted thiazolide compounds ROMARK LABORATORIES, L.C. (US) 2012-02-28 US disclosed
WO-2009035788-A1 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS ROMARK LABORATORIES L.C. (US) 2009-03-19 WO disclosed
US-20090036467-A1 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS ROMARK LABORATORIES L.C. 2009-02-05 US disclosed
US-20090036467-A1 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS ROMARK LABORATORIES L.C. 2009-02-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120122939-A1 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS HAVCR2, EIF2AK2, AADAC SCD 1845/4885ALDH1A1 1605/4885TSHR 1427/4885
US-20090036467-A1 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS HAVCR2, EIF2AK2, AADAC SCD 1845/4885ALDH1A1 1605/4885TSHR 1427/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.